A Multiple Unit Abuse-deterrent Dosage Form Based on Sodium Alginate

[1] Agüero L., Zaldivar-Silva D., Peña L., Dias ML. Alginate microparticles as oral colon drug delivery device: A review. Carbohydrate Polymers. 2017;168:32–43. https://doi.org/10.1016/j.carbpol.2017.03.033 AgüeroL. Zaldivar-SilvaD. PeñaL. DiasML. Alginate microparticles as oral colon drug delivery device: A review Carbohydrate Polymers. 2017 168 32 43 https://doi.org/10.1016/j.carbpol.2017.03.033 Search in Google Scholar

[2] Aldawsari, MF. et al. Development and Characterization of Calcium-Alginate Beads of Apigenin: In Vitro Antitumor, Antibacterial, and Antioxidant Activities. Mar. Drugs. 2021;19:467. https://doi.org/10.3390/md19080467 AldawsariMF. Development and Characterization of Calcium-Alginate Beads of Apigenin: In Vitro Antitumor, Antibacterial, and Antioxidant Activities Mar. Drugs. 2021 19 467 https://doi.org/10.3390/md19080467 Search in Google Scholar

[3] European Medicines Agency. Guideline on the pharmacokinetic and clinical evaluation of modified release dosage forms (EMA/CHMP/EWP/280/96 Rev1). 2013. (https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-pharmacokinetic-clinical-evaluation-modified-release-dosage-forms_en.pdf) European Medicines Agency Guideline on the pharmacokinetic and clinical evaluation of modified release dosage forms (EMA/CHMP/EWP/280/96 Rev1) 2013 (https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-pharmacokinetic-clinical-evaluation-modified-release-dosage-forms_en.pdf) Search in Google Scholar

[4] Gudin, J. Oxycodone DETERx^®: A Novel Abuse-Deterrent, Extended-Release Analgesic Option for the Treatment of Patients with Chronic Pain. Pain Ther. 2016;5:171–186. https://doi.org/10.1007/s40122-016-0062-1 GudinJ. Oxycodone DETERx^®: A Novel Abuse-Deterrent, Extended-Release Analgesic Option for the Treatment of Patients with Chronic Pain Pain Ther. 2016 5 171 186 https://doi.org/10.1007/s40122-016-0062-1 Search in Google Scholar

[5] Jedinger, N., Schrank, S., Fischer, JM. et al. Development of an Abuse- and Alcohol-Resistant Formulation Based on Hot-Melt Extrusion and Film Coating. AAPS PharmSciTech. 2016;17:68–77. https://doi.org/10.1208/s12249-015-0373-2 JedingerN. SchrankS. FischerJM. Development of an Abuse- and Alcohol-Resistant Formulation Based on Hot-Melt Extrusion and Film Coating AAPS PharmSciTech. 2016 17 68 77 https://doi.org/10.1208/s12249-015-0373-2 Search in Google Scholar

[6] Maddineni S. et al. Formulation optimization of hot-melt extruded abuse deterrent pellet dosage form utilizing design of experiments. Journal of Pharmacy and Pharmacology. 2014;2:309–322. https://doi.org/10.1111/jphp.12129 MaddineniS. Formulation optimization of hot-melt extruded abuse deterrent pellet dosage form utilizing design of experiments Journal of Pharmacy and Pharmacology. 2014 2 309 322 https://doi.org/10.1111/jphp.12129 Search in Google Scholar

[7] Mastropietro DJ. & Omidian H. Current approaches in tamper-resistant and abuse-deterrent formulations. Drug Development and Industrial Pharmacy. 2013;39:5,611–624. DOI: 10.3109/03639045.2012.680468 MastropietroDJ. OmidianH. Current approaches in tamper-resistant and abuse-deterrent formulations Drug Development and Industrial Pharmacy 2013 39 5 611 624 10.3109/03639045.2012.680468 Open DOISearch in Google Scholar

[8] Niño-Vásquez IA. et al. Co-microencapsulation: a promising multi-approach technique for enhancement of functional properties. Bioengineered. 2022;13:3,5168–5189. DOI: 10.1080/21655979.2022.2037363 Niño-VásquezIA. Co-microencapsulation: a promising multi-approach technique for enhancement of functional properties Bioengineered. 2022 13 3 5168 5189 10.1080/21655979.2022.2037363 Open DOISearch in Google Scholar

[9] Pasparakis G., Bouropoulos N. Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate–chitosan beads. International Journal of Pharmaceutics. 2006;323(1–2):34–42. https://doi.org/10.1016/j.ijpharm.2006.05.054 PasparakisG. BouropoulosN. Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate–chitosan beads International Journal of Pharmaceutics. 2006 323 1–2 34 42 https://doi.org/10.1016/j.ijpharm.2006.05.054 Search in Google Scholar

[10] Tian W., Mains J., Sleith DR. Immediate release abuse deterrent formulations (U.S. Patent No. US 2019/0117781 A1). 25 April 2019. U.S. Patent and Trademark Office. TianW. MainsJ. SleithDR. Immediate release abuse deterrent formulations (U.S.Patent No. US 2019/0117781 A1) 25 April 2019 U.S. Patent and Trademark Office Search in Google Scholar

[11] U.S. Department of Health and Human Services. General Principles for Evaluating the Abuse Deterrence of Generic Solid Oral Opioid Drug Products: Guidance for Industry. 2017. (https://www.fda.gov/media/96643/download) U.S. Department of Health and Human Services General Principles for Evaluating the Abuse Deterrence of Generic Solid Oral Opioid Drug Products: Guidance for Industry 2017 (https://www.fda.gov/media/96643/download) Search in Google Scholar

[12] Vasiukhina A. et al. PLA-PCL microsphere formulation to deter abuse of prescription opioids by smoking. International Journal of Pharmaceutics. 2022;626: 122151. https://doi.org/10.1016/j.ijpharm.2022.122151. VasiukhinaA. PLA-PCL microsphere formulation to deter abuse of prescription opioids by smoking International Journal of Pharmaceutics. 2022 626 122151 https://doi.org/10.1016/j.ijpharm.2022.122151. Search in Google Scholar

[13] Walter C., Knothe, C. & Lötsch, J. Abuse-Deterrent Opioid Formulations: Pharmacokinetic and Pharmacodynamic Considerations. Clin Pharmacokinet 2016;55:751–767. https://doi.org/10.1007/s40262-015-0362-3 WalterC. KnotheC. LötschJ. Abuse-Deterrent Opioid Formulations: Pharmacokinetic and Pharmacodynamic Considerations Clin Pharmacokinet 2016 55 751 767 https://doi.org/10.1007/s40262-015-0362-3 Search in Google Scholar